瑞马唑仑在老年人骨科手术麻醉中的应用
Application of Remimazolam in Anesthesia for Elderly Patients Undergoing Orthopedic Surgery
DOI: 10.12677/acm.2025.1541058, PDF,   
作者: 朱智纬:吉首大学医学院,湖南 吉首;路 璐:湖南医药学院总医院麻醉科,湖南 怀化
关键词: 瑞马唑仑老年人骨科手术Remimazolam Elderly Orthopedic Surgery
摘要: 随着我国老龄化进程的加快,老年患者在骨科手术中的麻醉管理面临独特挑战。瑞马唑仑(Remimazolam)是一种新型短效苯二氮卓类药物,以其快速起效、代谢独立于肝肾功能及可逆性强等优势,在老年骨科手术麻醉中展现出良好的应用前景。本文综述了瑞马唑仑的药理学特点、代谢机制及其在老年骨科手术中,尤其是腰麻术中程序性镇静的临床应用。研究表明,瑞马唑仑可有效维持血流动力学稳定,降低术后认知功能障碍(POCD)的发生率,并通过氟马西尼(Flumazenil)实现快速逆转,提高麻醉安全性和可控性。然而,其高昂成本和长期安全性仍需进一步研究。未来,优化瑞马唑仑的个体化麻醉策略,将有助于提升老年患者的手术安全性和术后恢复质量。
Abstract: With the acceleration of population aging in China, anesthetic management for elderly patients undergoing orthopedic surgery presents unique challenges. Remimazolam, a novel ultra-short-acting benzodiazepine, has demonstrated promising applications in geriatric orthopedic anesthesia due to its rapid onset, metabolism independent of hepatic and renal function, and strong reversibility. This review summarizes the pharmacological characteristics, metabolic mechanisms, and clinical applications of remimazolam in elderly orthopedic surgeries, particularly in procedural sedation for spinal anesthesia. Studies have shown that remimazolam effectively maintains hemodynamic stability, reduces the incidence of postoperative cognitive dysfunction (POCD), and enhances anesthesia safety and controllability through rapid reversal with flumazenil. However, its high cost and long-term safety require further investigation. In the future, optimizing individualized anesthetic strategies with remimazolam may improve surgical safety and postoperative recovery quality in elderly patients.
文章引用:朱智纬, 路璐. 瑞马唑仑在老年人骨科手术麻醉中的应用[J]. 临床医学进展, 2025, 15(4): 1302-1307. https://doi.org/10.12677/acm.2025.1541058

参考文献

[1] Wesolowski, A.M., Zaccagnino, M.P., Malapero, R.J., Kaye, A.D. and Urman, R.D. (2016) Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36, 1021-1027. [Google Scholar] [CrossRef] [PubMed]
[2] Kim, K.M. (2022) Remimazolam: Pharmacological Characteristics and Clinical Applications in Anesthesiology. Anesthesia and Pain Medicine, 17, 1-11. [Google Scholar] [CrossRef] [PubMed]
[3] Brohan, J. and Goudra, B.G. (2017) The Role of GABA Receptor Agonists in Anesthesia and Sedation. CNS Drugs, 31, 845-856. [Google Scholar] [CrossRef] [PubMed]
[4] Sneyd, J.R. (2023) Remimazolam—Current Status, Opportunities and Challenges. Anesthesiology and Perioperative Science, 1, Article No. 25. [Google Scholar] [CrossRef
[5] Lee, A. and Shirley, M. (2021) Remimazolam: A Review in Procedural Sedation. Drugs, 81, 1193-1201. [Google Scholar] [CrossRef] [PubMed]
[6] Zhao, T., Chen, D., Sun, H., Xu, Z., Lyu, S., Wang, T., et al. (2022) Moderate Sedation with Single-Dose Remimazolam Tosilate in Elderly Male Patients Undergoing Transurethral Resection of the Prostate with Spinal Anesthesia: A Prospective, Single-Arm, Single-Centre Clinical Trial. BMC Anesthesiology, 22, Article No. 247. [Google Scholar] [CrossRef] [PubMed]
[7] Chen, Y., Cai, Y., Yu, G., Zhang, X., Hu, T. and Xue, R. (2024) Safety and Effcacy of Remimazolam Tosilate for Sedation during Combined Spinal-Epidural Anesthesia for Orthopedic Procedures: A Randomized Controlled Trial. BMC Anesthesiology, 24, Article No. 75. [Google Scholar] [CrossRef] [PubMed]
[8] Noor, N., Legendre, R., Cloutet, A., Chitneni, A., Varrassi, G. and Kaye, A.D. (2021) A Comprehensive Review of Remimazolam for Sedation. Health Psychology Research, 9, Article 24514. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, J., Wang, X., Zhang, Q., Wang, Z. and Zhu, S. (2022) Application Effects of Remimazolam and Propofol on Elderly Patients Undergoing Hip Replacement. BMC Anesthesiology, 22, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
[10] Hu, Q., Liu, X., Wen, C., Li, D. and Lei, X. (2022) Remimazolam: An Updated Review of a New Sedative and Anaesthetic. Drug Design, Development and Therapy, 16, 3957-3974. [Google Scholar] [CrossRef] [PubMed]
[11] Dessai, S., Ninave, S. and Bele, A. (2024) The Rise of Remimazolam: A Review of Pharmacology, Clinical Efficacy, and Safety Profiles. Cureus, 16, e57260. [Google Scholar] [CrossRef] [PubMed]
[12] Kilpatrick, G.J. (2021) Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. Frontiers in Pharmacology, 12, Article 690875. [Google Scholar] [CrossRef] [PubMed]
[13] Kim, S. and Fechner, J. (2022) Remimazolam—Current Knowledge on a New Intravenous Benzodiazepine Anesthetic Agent. Korean Journal of Anesthesiology, 75, 307-315. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, M., Zhao, X., Yin, P., Bao, X., Tang, H. and Kang, X. (2022) Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress. Drug Design, Development and Therapy, 16, 3431-3444. [Google Scholar] [CrossRef] [PubMed]
[15] Garrett, A., Flowers, J., Ng, V. and Tobias, J.D. (2022) Remimazolam for Sedation during Upper Gastrointestinal Endoscopy in an Adolescent. Journal of Medical Cases, 13, 495-498. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, S., Cho, J.Y., Kim, M., Chung, J.M., Yang, J., Seong, C., et al. (2023) Safety and Efficacy of Remimazolam Compared with Midazolam during Bronchoscopy: A Single-Center, Randomized Controlled Study. Scientific Reports, 13, Article No. 20498. [Google Scholar] [CrossRef] [PubMed]
[17] Mao, Y., Guo, J., Yuan, J., Zhao, E. and Yang, J. (2022) Quality of Recovery after General Anesthesia with Remimazolam in Patients’ Undergoing Urologic Surgery: A Randomized Controlled Trial Comparing Remimazolam with Propofol. Drug Design, Development and Therapy, 16, 1199-1209. [Google Scholar] [CrossRef] [PubMed]
[18] Sato, T. and Nishiwaki, K. (2022) Remimazolam Should Be Antagonized by an Adequate Flumazenil. Journal of Anesthesia, 37, 164-165. [Google Scholar] [CrossRef] [PubMed]
[19] Zhu, T. (2023) Hemodynamic Influences of Remimazolam versus Propofol during the Induction Period of General Anesthesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pain Physician Journal, 26, E761-E773. [Google Scholar] [CrossRef
[20] Pastis, N.J., Yarmus, L.B., Schippers, F., Ostroff, R., Chen, A., Akulian, J., et al. (2019) Safety and Efficacy of Remimazolam Compared with Placebo and Midazolam for Moderate Sedation during Bronchoscopy. Chest, 155, 137-146. [Google Scholar] [CrossRef] [PubMed]
[21] Oh, E.J., Chung, Y.J., Lee, J., Kwon, E.J., Choi, E.A., On, Y.K., et al. (2023) Comparison of Propofol vs. Remimazolam on Emergence Profiles after General Anesthesia: A Randomized Clinical Trial. Journal of Clinical Anesthesia, 90, Article 111223. [Google Scholar] [CrossRef] [PubMed]
[22] Dundee, J.W., Halliday, N.J., Harper, K.W. and Brogden, R.N. (1984) Midazolam a Review of Its Pharmacological Properties and Therapeutic Use. Drugs, 28, 519-543. [Google Scholar] [CrossRef] [PubMed]
[23] Kimoto, Y., Hirano, T., Kuratani, N., Cavanaugh, D. and Mason, K.P. (2023) Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases. Journal of Clinical Medicine, 12, Article 3930. [Google Scholar] [CrossRef] [PubMed]